gw8510 has been researched along with Pancreatic Neoplasms in 1 studies
GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "GW8510 was found to synergize with gemcitabine to inhibit PANC-1 cell viability and migration." | 1.62 | Synergistic Interactions between GW8510 and Gemcitabine in an In Vitro Model of Pancreatic Cancer. ( Ak, H; Atay, S; Aydin, HH; Rüstem, DG, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rüstem, DG | 1 |
| Atay, S | 1 |
| Aydin, HH | 1 |
| Ak, H | 1 |
1 other study available for gw8510 and Pancreatic Neoplasms
| Article | Year |
|---|---|
Synergistic Interactions between GW8510 and Gemcitabine in an In Vitro Model of Pancreatic Cancer.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Cell Survival; Computationa | 2021 |